4USA. Orphan Drug Act [M]. Pub Law USC, 1983, (4) : 97- 414.
5Thamer M,Brenan N,Srmansky R. A cross national Comparison of orphan drug policies: implications for the US Orphan Drug Act[J]. J Health polit policy law, 1998,23(2) :265-269.
6Meyers AS. Orphan Drugs:the current situation in the United States,Europe,and Asia[J]. Drug Inf J,1997,31(1) :101-105.
7Meyers AS. History of the American Orphan Drug Act [R]. In ternational conference of rare disease and orphan drugs. Spain, 2000.
8教育部.马克思主义政治经济学原理[M].北京:高等教育出版社,2004.153-180
9张伦.罕见病治疗药物的开发大有潜力.中国药业,2002,(8).
10Linthorst G,Hollak C.European ordinance on orphan drugs:changes and threats[J].Ned Tijdschr Geneeskd,2003,147(4):143-145.
